Treating SEGA in Patients with Tuberous Sclerosis Complex

At the American Academy of Neurology (AAN) Annual Meeting in Vancouver, Canada, we talked with Steven Sparagana, MD of the Texas Scottish Rite Hospital for Children about subependymal giant cell astrocytoma (SEGA) treatment patterns among patients with tuberous sclerosis complex (TSC). SEGAs are benign brain lesions that occur in 10% to 20% of TSC patients.

Reference
Krueger D, Song J, Swallow E, et al. Subependymal Giant Cell Astrocytoma Treatment Patterns among Patients with Tuberous Sclerosis Complex. Poster presented at: 68th Annual Meeting of the American Academy of Neurology; April 15-21, 2016; Vancouver, BC.

To read the abstract, go to http://www.abstractsonline.com..../pp8/#!/4046/present